AVECRIS is addressing one of gene therapy&s;s most difficult challenges: long-lasting, cell-type-specific expression.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
AVECRIS platform extends the capabilities of mRNA / RNA approaches. AVECRIS provides the following services: cell-type specific gene expression / Protein expression that is stable and long-lasting / Non-integrating, unlikely to elicit innate immunity / Redosable and titratable / Unprecedented ability to deliver mitochondrial gene therapy / A DNA-based backbone construct that is universal, unmodified, and has a modular coding region that allows for rapid and infinite application programming / Manufacturing that is quick, dependable, highly scalable, and low-cost.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2022 | Venture Round | 1 | $3.6M |
Alameda Research Alameda Research |
8/2022 | Grant | 1 | $5k |
WheelsUP Accelerator WheelsUP Accelerator |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|